copper peptides ghk cu GHK-Cu 50mg 1 and Palmitoyl Tetrapeptide GHK-Cu: The Copper Peptide for

Gastrointestinal Research BPC-157s origin in gastric tissue has made gut-healing research a parallel and long-standing focus, particularly regarding intestinal anastomosis and ulcer models (Sikiric et al., 2018)

Anatomical sites, local vs systemic delivery, and rotation

What stood out: CagriSema achieved 23.0% weight loss at 84 weeks (efficacy estimand) Tirzepatide achieved 25.5% On the treatment-regimen estimand, weight loss was 20.2% vs 23.6% Primary endpoint not met: CagriSema did not demonstrate non-inferiority vs tirzepatide on weight loss at 84 weeks Why this matters This is a reminder that in obesity pharmacotherapy, very effective and best-in-class are not the same conversation

However, it remains investigational and is not yet approved by the FDA for routine therapeutic use

NAD+ is a coenzyme every cell uses to produce energy and run repair and metabolism

Can Vet J 1996;37:2379